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Bendavia (mTp-131), a novel miTochondria-TargeTing pepTide, improves acTiviTy and 
expression of cyTochrome-c oxidase and aTTenuaTes mediaTors of cardiomyocyTe 
apopTosis in lefT venTricular myocardium of dogs wiTh advanced hearT failure
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introduction: Dysfunctional mitochondria (MITO) and cardiomyocyte apoptosis occur in heart failure (HF). Bendavia (MTP-131), a first-in-class 
MITO protective agent, improves LV function and ATP synthesis in HF dogs. We examined the effects of Bendavia on protein level and activity of 
cytochrome-c oxidase complex IV (COXIV), a contributor to MITO ATP synthesis, and on protein level of cytosolic cytochrome-c (CCC), a mediator of 
apoptosis, in LV of dogs with microembolization-induced HF (LV ejection fraction ~30%).
methods: 12 HF dogs were randomized to 3 months therapy with subcutaneous injections of Bendavia (0.5 mg/kg once daily, n=7) or saline 
(Control, n=7). LV tissue obtained at end of therapy and from 6 normal (NL) dogs was used to measure COXIV activity polarographically and protein 
level of COXIV, CCC and β-actin, an internal control, by Western blotting in homogenate and cytosolic fraction.
results: β-actin level was unchanged among groups. COXIV activity and protein level were reduced and CCC protein level was increased in HF 
Controls compared to NL (Table). Bendavia increased the activity and protein level of COXIV and decreased protein level of CCC to near NL (Table).
conclusions: Downregulation of COXIV activity and expression and upregulation of CCC protein level in LV of HF dogs favor a state of energy 
deprivation and enhanced apoptosis. Bendavia restores regulation of COXIV and CCC to near normal levels; a correction that favors improved 
myocardial energetics and reduced apoptosis in HF.
TABLE
NL HF-Control HF-Bendavia
COXIV Activity
(nmols molecular oxygen/min/mg protein)
7506 ± 282 4220± 240* 6509 ± 443†
β-actin in homogenate (du)
β-actin in cytosol (du)
0.44 ± 0.51
0.33 ± 0.06
0.41 ± 0.04
0.31 ± 0.06
0.45 ± 0.06
0.37 ± 0.06
COXIV protein (du) 0.61 ± 0.05 0.18 ± 0.02* 0.40 ± 0.06†
CCC protein (du) 0.34 ± 0.02 0.75± 0.08* 0.39 ± 0.02†
du=densitometric units; *=p<0.05 vs. NL; †=p<0.05 vs. HF-Control
